Idorsia Ltd (0RQE)

Currency in CHF
2.498
-0.075(-2.91%)
Real-time Data·
0RQE Scorecard
Full Analysis
Operates with a significant debt burden
0RQE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4502.660
52 wk Range
0.6333.605
Key Statistics
Bid/Ask
2.37 / 2.615
Prev. Close
2.573
Open
2.66
Day's Range
2.45-2.66
52 wk Range
0.633-3.605
Volume
65.55K
Average Volume (3m)
65.58K
1-Year Change
21.14%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0RQE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Idorsia Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Idorsia Ltd Company Profile

ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.

Compare 0RQE to Peers and Sector

Metrics to compare
0RQE
Peers
Sector
Relationship
P/E Ratio
−4.0x−3.4x−0.6x
PEG Ratio
0.01−0.100.00
Price/Book
−0.5x2.3x2.6x
Price / LTM Sales
2.5x8.0x3.3x
Upside (Analyst Target)
-135.8%40.1%
Fair Value Upside
Unlock7.4%5.3%Unlock

Earnings

Latest Release
Dec 02, 2022
EPS / Forecast
-0.06 / --
Revenue / Forecast
438.00K / --
EPS Revisions
Last 90 days

0RQE Income Statement

People Also Watch

9.84
AMS
-2.86%
102.20
NOVN
+1.29%
172.10
KNIN
+0.61%

FAQ

What Stock Exchange Does Idorsia Ltd Trade On?

Idorsia Ltd is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Idorsia Ltd?

The stock symbol for Idorsia Ltd is "0RQE."

What Is the Idorsia Ltd Market Cap?

As of today, Idorsia Ltd market cap is 506.75M.

What Is Idorsia Ltd's Earnings Per Share (TTM)?

The Idorsia Ltd EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 0RQE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Idorsia Ltd Stock Split?

Idorsia Ltd has split 3 times.

What is the current trading status of Idorsia Ltd (0RQE)?

As of 20 Aug 2025, Idorsia Ltd (0RQE) is trading at a price of 2.50, with a previous close of 2.57. The stock has fluctuated within a day range of 2.45 to 2.66, while its 52-week range spans from 0.63 to 3.61.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.